Most recent deal Monday, September 28, 2026.
Creates a unified life sciences offering that connects market research, strategy, creative, and field execution for pharmaceutical and biotech clients.
The acquired practice brings experience across a wider range of security technologies. Its clients will retain their existing team members and service relationships while gaining access to CloudFirst’s broader services.
The deal adds investment platform advisory, implementation, and post-launch support to F2’s offering, bringing proprietary delivery tools for complex financial services deployments in Canada.
The acquisition adds a virtual commercial operations capability that bridges access strategy and field execution for pharmaceutical and biotech clients.
